Cite
HARVARD Citation
Allegretti, J. et al. (n.d.). S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection. American journal of gastroenterology. pp. S63-S64. [Online].